Skip to main content

Table 2 Computation of sample size

From: Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)

Expected prevalence of responders Number of responders Number of non responders Total sample size
50% 82 82 164
33% 63 125 188
28% 59 146 205